Generic Name and Formulations:
Nitroglycerin 0.3mg, 0.4mg, 0.6mg; sublingual tabs.
Indications for NITROSTAT:
Acute relief of angina attack. Acute prophylaxis of angina pectoris.
Use lowest effective dose. Treatment: 1 tab sublingually or in buccal pouch at onset, may repeat in 5mins; max 3 tabs in 15mins. Prophylaxis: 5–10mins before activity.
Severe anemia. Increased intracranial pressure (eg, cerebral hemorrhage, traumatic brain injury). Acute circulatory failure or shock. Concomitant PDE-5 inhibitors (eg, avanafil, sildenafil, tadalafil, vardenafil), soluble guanylate cyclase stimulators (eg, riociguat).
Constrictive pericarditis, aortic or mitral stenosis, volume-depleted, hypotensive: increased risk of severe hypotension. Hypertrophic cardiomyopathy. Elderly. Pregnancy. Nursing mothers: not studied.
See Contraindications. Hypotension potentiated by PDE-5 inhibitors, riociguat. Avoid ergotamine and related drugs.
Headache, dizziness, paresthesia, vertigo, weakness, palpitation, postural hypotension, syncope, flushing, rash, exfoliative dermatitis.
Tabs 0.4mg—4 x 25, 100; 0.3mg, 0.6mg—100
Neurology Advisor Articles
- Deep Brain Stimulation Improves Parkinson Disease in Older Adults
- Optimizing Treatment for Patients With Chronic Sciatica: Gabapentin vs Pregabalin
- Tiglutik Now Available for the Treatment of Amyotrophic Lateral Sclerosis
- Modifiable CV Risk Factors Within Healthy Range Indicative of CV Morphology, White Matter Lesions
- A New Look at Demyelination and White Matter Density in Multiple Sclerosis